Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Hair loss in women linked to higher sexual dysfunction risk.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

PCOS is linked to low-grade chronic inflammation.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Adequate vitamin D might lower, and high hair chromium might increase DNA damage in obese women.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.